Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Falck

Showing results (431-440 of 692) with videos related to

Pageof 70
Sort By:
The Journal of Biological Chemistry|May 27, 2005
Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipidsAmbra Pozzi, Ines Macias-Perez, Tristin Abair, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 23, 2012
Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunctionJennifer Cheng, Victor Garcia, Yan Ding, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2009
Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensiveElvira L Liclican, Anabel B Doumad, Jianjin Wang, et al.
Journal of Cardiovascular Pharmacology|June 26, 2026
Effect of EET-A treatment on Cardiac Hypertrophy Induced by Isoproterenol in Sprague-Dawley RatsSara A Helal, Samar H Gerges, Keshav Gopal, et al.
The Journal of Biological Chemistry|June 15, 2016
20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTORÜzen Savas, Shouzou Wei, Mei-Hui Hsu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 29, 2008
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heartGarrett J Gross, Kathryn M Gauthier, Jeannine Moore, et al.
The Journal of Biological Chemistry|September 30, 1994
Activation of nuclear factor kappa B and oncogene expression by 12(R)-hydroxyeicosatrienoic acid, an angiogenic factor in microvessel endothelial cellsM Laniado-Schwartzman, Y Lavrovsky, R A Stoltz, et al.
Science (New York, N.Y.)|September 10, 2016
Dirhodium-catalyzed C-H arene amination using hydroxylaminesMahesh P Paudyal, Adeniyi Michael Adebesin, Scott R Burt, et al.
The Journal of Biological Chemistry|June 25, 1993
Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenaseA Karara, K Makita, H R Jacobson, et al.
Circulation Research|May 23, 2002
14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteriesKathryn M Gauthier, Christina Deeter, U Murali Krishna, et al.
Pageof 70

Showing results (431-440 of 692) with videos related to

Sort By:
Pageof 70
The Journal of Biological Chemistry|May 27, 2005
Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipidsAmbra Pozzi, Ines Macias-Perez, Tristin Abair, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 23, 2012
Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunctionJennifer Cheng, Victor Garcia, Yan Ding, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2009
Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensiveElvira L Liclican, Anabel B Doumad, Jianjin Wang, et al.
Journal of Cardiovascular Pharmacology|June 26, 2026
Effect of EET-A treatment on Cardiac Hypertrophy Induced by Isoproterenol in Sprague-Dawley RatsSara A Helal, Samar H Gerges, Keshav Gopal, et al.
The Journal of Biological Chemistry|June 15, 2016
20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTORÜzen Savas, Shouzou Wei, Mei-Hui Hsu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 29, 2008
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heartGarrett J Gross, Kathryn M Gauthier, Jeannine Moore, et al.
The Journal of Biological Chemistry|September 30, 1994
Activation of nuclear factor kappa B and oncogene expression by 12(R)-hydroxyeicosatrienoic acid, an angiogenic factor in microvessel endothelial cellsM Laniado-Schwartzman, Y Lavrovsky, R A Stoltz, et al.
Science (New York, N.Y.)|September 10, 2016
Dirhodium-catalyzed C-H arene amination using hydroxylaminesMahesh P Paudyal, Adeniyi Michael Adebesin, Scott R Burt, et al.
The Journal of Biological Chemistry|June 25, 1993
Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenaseA Karara, K Makita, H R Jacobson, et al.
Circulation Research|May 23, 2002
14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteriesKathryn M Gauthier, Christina Deeter, U Murali Krishna, et al.
Pageof 70